公开(公告)号：US20070074641A1

公开(公告)日：2007-04-05

申请号：US10576678

申请日：2004-10-15

申请人： Rainer Dyllick-Brenzinger ,  Thomas Kebler ,  Norbert Guntherberg ,  Peter Witt ,  Roland Ettl

发明人： Rainer Dyllick-Brenzinger ,  Thomas Kebler ,  Norbert Guntherberg ,  Peter Witt ,  Roland Ettl

IPC分类号： C08L3/00 ,  D21H17/00

CPC分类号： D21H21/16 ,  D21H17/17 ,  D21H17/28 ,  D21H17/72 ,  D21H23/04 ,  D21H23/22

摘要： Solid mixtures of a reactive size and starch, which are obtainable by mixing at least one reactive size with at least one starch in a melt in the presence of at least one destructuring agent for starch under the action of shear forces at from 65 to 250° C. and cooling the melt to room temperature, are used in the form of aqueous dispersions as process assistants in papermaking.

摘要翻译： 反应性大小和淀粉的固体混合物，其可通过在至少一种反应性大小与至少一种淀粉在熔体中在至少一种淀粉破坏剂的存在下在65至250°的剪切力作用下混合而得到 并将熔体冷却至室温，以水分散体的形式用作造纸中的加工助剂。

公开(公告)号：US4672030A

公开(公告)日：1987-06-09

申请号：US702284

申请日：1985-02-15

申请人： Peter Witt

发明人： Peter Witt

IPC分类号： C12Q1/56 ,  G01N33/86

CPC分类号： G01N33/86 ,  G01N2400/40 ,  Y10S435/81

摘要： Partial thromboplastin time (PTT) is determined for monitoring and controlling heparin therapy with a test kit having increased sensitivity to heparin. Increased sensitivity is obtained by including with reagents in the test kit an organic sulfuric acid or salt thereof such as dodecylbenzenesulfuric acid--sodium salt and/or an organic sulfuric acid ester or salt thereof such as sodium laurylsulfate.

摘要翻译： 使用具有增加的肝素敏感性的测试试剂盒，确定部分凝血活酶时间（PTT）用于监测和控制肝素治疗。 通过在试剂盒中使用试剂包括有机硫酸或其盐如十二烷基苯磺酸钠盐和/或有机硫酸酯或其盐如十二烷基硫酸钠来获得增加的灵敏度。

公开(公告)号：US4902621A

公开(公告)日：1990-02-20

申请号：US93936

申请日：1987-09-08

申请人： Peter Witt

发明人： Peter Witt

IPC分类号： C12N9/96 ,  C12Q1/34 ,  C12Q1/40 ,  G01N33/50

CPC分类号： C12Q1/40 ,  C12N9/96 ,  C12Q2334/10

摘要： An aqueous stabilized enzyme preparation to be used for measuring the amount of .alpha.-amylase in a liquid sample like serum or urine containing a blocked and labeled oligosaccharide being the substrate for the .alpha.-amylase to be measured in the presence of exo-enzymes which aqueous preparation, preferably consisting of two separate solutions is stabilized by adding a buffer, a taurocholic acid derivative, an albumin, and a polyhydric alcohol.